DHT Tubestop Playbook
DHT Tubestop Interactive Map
Navigate the Digital Health Technology lifecycle. Click any Phase Node or Stop Button to access operational deep-dives.
Phase I: Program Planning
Setting the strategic foundation and procurement standards for Digital Health Technology across the clinical development portfolio.
Stop 1.1: Operational Strategy & Feasibility
Defining long-term digital vision and evaluating population-specific technical viability.
Enter StopStop 1.2: Procurement & Quality
Selection and qualification of specialized tech vendors and 21 CFR Part 11 compliance.
Enter StopStop 1.1: Operational Strategy & Feasibility
Description
This stop ensures that DHT implementation is treated as a strategic program-level decision rather than a one-off trial gadget. The focus is on aligning technical specifications with the clinical science goals and assessing if the target patient population can successfully interact with the tech.
Substops
RACI
1.1.1 Create a DHT Strategic Operations Plan
Description
The Strategic Operations Plan acts as the foundational roadmap for DHT use. It defines how digital data will be integrated into the broader data lifecycle and ensures that the technology selected supports the required statistical rigor of the program.
Key Considerations
References & Citations
RACI
1.1.2 Conduct DHT Feasibility Assessment
Description
Feasibility assessment involves evaluating the "human side" of the technology. It determines if the intended patients have the technical literacy, infrastructure (Wi-Fi/Cellular), and physical capability to use the device as intended without excessive burden.
Key Considerations
References & Citations
RACI
Stop 1.2: Procurement & Quality
Description
This stop establishes the framework for selecting and managing DHT vendors. Because the technology and the data it generates are regulated as medical devices and electronic records, vendor qualification must be exceptionally rigorous, focusing on stability, security, and compliance.
Substops
RACI
1.2.1 Vendor Selection & Qualification
Description
Identifying vendors who can meet the technical and regulatory requirements of a clinical trial. Audits must confirm 21 CFR Part 11 compliance, data encryption standards, and a robust Quality Management System (QMS).
Key Considerations
References & Citations
RACI
1.2.2 Contracts & Vendor Management
Description
Establishing enforceable agreements that protect the sponsor's data and the participant's privacy. Contracts must clearly define data ownership, service level agreements (SLAs), and the management of firmware or software updates mid-trial.
Key Considerations
References & Citations
RACI
Phase II: Trial Planning
The design phase where clinical intent meets technical validation. This phase includes the iterative DHT Selection Loop.
Stop 2.0: DHT Selection & Assessment (Loop)
Verification, Analytical Validation, and Clinical Validation (V3) before protocol lock.
Enter LoopStop 2.1: Clinical Endpoints Validation
Mapping raw data to meaningful clinical outcomes and patient benefit.
Enter StopStop 2.2: Statistical & Data Planning
Designing data architecture, SAP, and cybersecurity infrastructure.
Enter StopStop 2.3: Protocol Design & Ethics
Integrating DHT procedures and privacy ethics into the master study document.
Enter StopStop 2.0: DHT Selection & Assessment (Loop)
Description
This iterative loop is the "Heart" of DHT planning. It ensures that the technology is scientifically sound and regulatory-ready before the protocol is finalized.
Core Requirements: The V3 Framework
- Verification: Bench testing to confirm hardware/software specs.
- Analytical Validation: Confirming the algorithm accurately measures the physiological/behavioral parameter.
- Clinical Validation: Proving the measure is meaningful in the target population.
Watchout: "Context of Use" (CoU). A device validated for heart rate in healthy runners is NOT validated for heart rate in patients with AFib. Validation must match the trial population.
RACI
Stop 2.1: Clinical Endpoints Validation
Description
This stop defines the scientific purpose of the digital data. We must differentiate between objective biomarkers and patient-focused Clinical Outcome Assessments (COAs).
Critical Planning Steps:
- Describe clinical meaningfulness from the patient's perspective.
- Align DHT data (primary vs exploratory) with protocol endpoints.
- Establish sensitivity/specificity targets for the digital measure.
References & Citations
FDA: Biomarker Qualification Evidentiary FrameworkLaunch CTTI: Novel Endpoint DevelopmentLaunchRACI
Stop 2.2: Statistical & Data Planning
Description
High-frequency DHT data requires a specialized architecture. This stop moves from clinical intent to the "Data Pipeline" design.
Technical Deliverables:
- Data Architecture Diagram: Mapping raw data flow from device to DB.
- Statistical Analysis Plan (SAP): Defining how to handle missing data and "noise".
- Cybersecurity Plan: Encryption at rest/transit per ALCOA+ principles.
Watchout: Data Volume. Ensure your database can scale to handle millions of data points without crashing analysis tools.
References & Citations
FDA: Cybersecurity in Medical DevicesLaunchRACI
Stop 2.3: Protocol Design & Ethics
Description
The final lock. Here, DHT procedures are hard-coded into the study protocol and ethics submissions.
Key Documentation:
- Intended Use: Defining if DHT data is for safety, primary, or exploratory use.
- Privacy Ethics: Addressing potential for inducement or over-surveillance.
- Informed Consent: Transparent language on data access and technical burden.
References & Citations
FDA: Decentralized Clinical Trials (DCT) GuidanceLaunchRACI
Phase III: Study Start Up
Orchestrating the transition from digital strategy to clinical execution. Focus: Quality release, logistics, and site/patient readiness.
Stop 3.1: Documentation Finalization
Approval of SAP/DMP and tech addendums for data integrity.
Enter Stop →Stop 3.2: Procurement & Logistics
Supply chain management, hardware inspections, and global distribution.
Enter Stop →Stop 3.3: Site & Patient Enablement
Hands-on training, patient resources, and informed consent execution.
Enter Stop →Stop 3.1: Documentation Finalization
Description
Finalizing the technical and statistical documentation required to ensure DHT data meets ALCOA+ standards. This stop bridges the gap between the study protocol and the actual data management workflows.
Substops
Stop RACI
3.1.1 Finalize Statistical Analysis Plan (SAP)
Technical Deep Dive
The SAP must handle high-frequency DHT data by defining the algorithms that transform raw sensor signals into clinical endpoints.
- Algorithm version lock and validation status.
- Definition of "Wear Time" compliance (e.g., 10 hrs/day).
- Imputation rules for missing digital data.
RACI
3.1.2 Finalize Data Management Plan (DMP)
Technical Deep Dive
Focuses on data architecture, security, and the path from device to database.
- Encryption at rest (AES-256) and in transit (TLS 1.2).
- Data reconciliation between device and Subject ID.
- Audit trail requirements for automated data transfers.
RACI
Stop 3.2: Procurement & Logistics
Description
The physical mobilization of technology. This stop involves procuring devices, verifying they meet technical standards, and managing the global supply chain.
Substops
Stop RACI
3.2.1 Procurement of Devices
Technical Deep Dive
Acquisition of hardware models identified in Phase II. Ensures devices are stock-ready for initial site activation.
- Inventory buffering for site replacements.
- Region-specific telecommunication certificates.
RACI
3.2.2 First Article Inspection (FAI)
Technical Deep Dive
Quality gate to ensure firmware and software pre-loads match technical specifications.
- Firmware version consistency across serial numbers.
- Battery performance baseline testing.
RACI
3.2.3 Logistics and Trial Supplies Management
Technical Deep Dive
Global distribution management and reverse logistics for device retrieval or malfunction repair.
- Customs HS Code identification.
- Provisioning of prepaid return shipping kits.
RACI
Stop 3.3: Site & Patient Enablement
Description
Transforming complex technical requirements into actionable human workflows. Focuses on training clinical staff and providing participant resources.
Substops
Stop RACI
3.3.1 Create Patient-Facing Materials
Technical Deep Dive
Development of troubleshooting guides and visual manuals for participant success.
- Step-by-step syncing and charging guides.
- 6th-8th grade reading level health literacy review.
RACI
3.3.2 Site Set-up and Training
Technical Deep Dive
Site Initiation visits including hands-on tech workshops for study coordinators.
- Coordinator certification on device setup.
- Site-facing technical manual distribution.
RACI
3.3.3 Patient Consent & Oversight
Technical Deep Dive
Ensuring the Informed Consent Form covers digital privacy, data encryption, and device expectations.
- Clear language on data de-identification.
- Indication if device provides real-time medical alerts.
RACI
Phase IV: Study Conduct
The operational heart of the trial: Real-time oversight of participant adherence, data quality, and management of mid-trial technical updates.
Stop 4.1: Operational Execution & Support
Managing ongoing helpdesks, technical troubleshooting, and safety signal triage.
Enter Stop →Stop 4.2: Data Monitoring & Compliance
Oversight of data flow quality, participant compliance, and mid-study technology updates.
Enter Stop →Stop 4.1: Operational Execution & Support
Description
Active support for participants and sites to ensure continuous data capture. This stop involves maintaining the technical helpdesk and responding to physiological alerts triggered by DHT data.
Substops
Stop RACI
4.1.1 User Support & Technical Troubleshooting
Technical Deep Dive
Maintenance of the 24/7 technical support structure. Effective troubleshooting minimizes "Data Gaps" which can compromise statistical powering.
- Tiered support desk SLAs (Response within 2-4 hours).
- Knowledge Base (FAQ) updates based on live participant feedback.
- Device sync status monitoring.
RACI
4.1.2 Ongoing Procurement & Supply Management
Technical Deep Dive
Managing the flow of replacement devices. Ensures participants receive new hardware within 24-48 hours of a reported failure.
- Monitoring of "Buffer Stock" levels at sites or central hubs.
- Refurbishment process for returned faulty hardware.
RACI
4.1.3 Safety Reporting & Signal Response
Technical Deep Dive
The workflow for triaging real-time physiological alerts. This stop bridges the gap between digital "noise" and Serious Adverse Events (SAEs).
- Validation of alert thresholds in the software.
- Immediate escalation path to the Medical Monitor for "Red Flags."
RACI
Stop 4.2: Data Monitoring & Compliance
Description
Oversight of the incoming data stream quality and participant adherence. This stop also manages mid-study technical changes, such as security patches or OS updates.
Substops
Stop RACI
4.2.1 Ongoing Data Management & Monitoring
Technical Deep Dive
Oversight of automated data transfers. Ensuring that "raw" sensor data is being correctly transformed into "metrics" per the SAP.
- Audit trail review for data transfers.
- Cleaning of artifacts or technical noise from the data stream.
RACI
4.2.2 Participant Adherence & Compliance Monitoring
Technical Deep Dive
Identifying participants who are not meeting "Wear Time" or "Sync" requirements. Allows for proactive intervention from the site.
- Review of "Compliance Dashboards."
- Automated notifications to participants (SMS/Push) for missed syncs.
RACI
4.2.3 Security Updates & Re-consent Management
Technical Deep Dive
Governance of mid-trial technology changes. Security patches must be deployed without disrupting data collection.
- Impact assessment for every firmware/app update.
- Coordination with IRB for updates requiring re-consent.
RACI
Phase V: Study Closeout & Analysis
The wrap-up phase: Reconciling hardware, locking the digital data stream, and extracting participant insights for future digital strategy.
Stop 5.1: Closeout Activities & Feedback
Device retrieval, supply reconciliation, and gathering participant user experience insights.
Enter Stop →Stop 5.2: Final Analysis & Reporting
Final statistical execution on digital endpoints and documenting lessons learned.
Enter Stop →Stop 5.1: Closeout Activities & Feedback
Description
This stop manages the "Reverse Logistics" of the DHT lifecycle. It involves the physical retrieval of devices from sites and participants and the reconciliation of inventory against enrollment data.
Substops
Stop RACI
5.1.1 Final Procurement & Data Destruction
Technical Deep Dive
Closing the financial and technical loops with the vendor. For DHTs, this involves "Data Destruction" or "Sanitization" of returned hardware to protect patient privacy (GDPR/HIPAA).
- Certificate of Data Destruction for every returned device serial number.
- Final vendor payment reconciliation based on device loss/theft rates.
- Archive of cloud data portals into the Trial Master File (TMF).
RACI
5.1.2 Supply Reconciliation (DHT Hardware)
Technical Deep Dive
Physical accounting of all DHT assets. Reconciliation must match the "Procured Amount" vs. "Enrollment Use" vs. "Broken/Lost" units.
- Reconciliation of site-level inventory logs against central shipping logs.
- Documentation of "Lost to Follow-up" devices for financial write-off.
- Shipping confirmation for bulk device returns to refurbish/recycle center.
RACI
5.1.3 Participant Feedback & Engagement
Technical Deep Dive
Crucial for future DHT selection. Gathering insights on "Technical Burden"—was the device comfortable, easy to sync, and non-stigmatizing?
- Analysis of participant satisfaction surveys.
- Correlation of participant feedback with actual compliance (wear-time) data.
- Closing the loop with participants: Thank you letters and study result summaries.
RACI
Stop 5.2: Final Analysis & Reporting
Description
The transition from "Clean Data" to "Clinical Evidence." This stop involves the final statistical processing of digital endpoints and the formal documentation of what went right (and wrong) operationally.
Substops
Stop RACI
5.2.1 Final Statistical Analysis
Technical Deep Dive
Execution of the "Algorithm Lock." Processing the full longitudinal digital dataset to determine treatment effect on the digital primary/secondary endpoints.
- Final imputation of missing data per the SAP.
- Validation of algorithm performance against any "gold standard" used in Phase II.
- Preparation of digital data for regulatory submission (SDTM/ADaM datasets).
RACI
5.2.2 Documenting Lessons Learned
Technical Deep Dive
Evaluating the "Tubestop" process. Did the technology choice, logistics provider, and training program meet the study goals? This feeds into the next program-level planning cycle.
- Analysis of technical support tickets (identifying common device failure points).
- Vendor Performance Review (SLA adherence).
- Operational post-mortem report for the Digital Strategy team.
